Modular Access to C2’‐Aryl/Alkenyl Nucleosides with Electrochemical Stereoselective Cross‐Coupling
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202418806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Jia-Bao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Zhangjiang Institute for Advanced Study, Shangha…. Hauptthemen laut MEDLINE: Nucleosides, Electrochemical Techniques, Alkenes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Xiangfu Lab Research Project.
Abstract (Originalsprache)
Chemically modified oligonucleotides have garnered significant attention in medicinal chemistry, chemical biology, and synthetic biology due to their enhanced stability in vivo compared to naturally occurring oligonucleotides. However, current methods for synthesizing modified nucleosides, particularly at the C2’‐position, are limited in terms of efficiency, modularity, and selectivity. Herein, we report a new approach for the synthesis of highly functionalized C2’‐α‐aryl/alkenyl nucleosides via an electrochemical nickel‐catalyzed cross‐coupling of 2’‐bromo nucleosides with a variety of (hetero)aryl and alkenyl iodides. This method affords a diverse array of C2’‐ α‐aryl/alkenyl nucleosides with excellent stereoselectivity, broad substrate scope, and good functional group compatibility. We further synthesized oligonucleotides incorporating C2’‐aryl‐modified thymidine moieties and demonstrated that their annealed double‐stranded DNAs exhibit decreased melting temperatures (Tm). Additionally, oligonucleotides with C2’‐aryl modifications at the 3’ end showed enhanced resistance to 3’‐exonuclease degradation and C2’‐aryl modifications did not impede the cellular uptake process, highlighting the potential of these modified oligonucleotides for therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai, 200240, People's Republic of China.
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
- Jiaxing Key Laboratory of Biosemiconductors, Xiangfu Laboratory, Jiashan, 314102, Zhejiang, People's Republic of China.
- School of Chemical Science and Engineering, Tongji University, Siping Road 1239, Shanghai, People's Republic of China.
ORCID-Profile: Yong Nian
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Xiangfu Lab Research Project
- National Key R&D Program of China
- National Key Research and Development Program of China
Zitieren
APA
Wang, J. B., Shen, Y., Yan, Q. L., Kong, W. J., Nian, Y., & Shang, M. (2025). Modular Access to C2’‐Aryl/Alkenyl Nucleosides with Electrochemical Stereoselective Cross‐Coupling. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202418806
Vancouver
Wang JB, Shen Y, Yan QL, Kong WJ, Nian Y, Shang M. Modular Access to C2’‐Aryl/Alkenyl Nucleosides with Electrochemical Stereoselective Cross‐Coupling. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202418806
BibTeX
@article{Wang2025,
author = {Wang, Jia-Bao and Shen, Yu and Yan, Qing-Long and Kong, Wei-Jun and Nian, Yong and Shang, Ming},
title = {Modular Access to C2’‐Aryl/Alkenyl Nucleosides with Electrochemical Stereoselective Cross‐Coupling},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202418806}
}
EUVIMED